Neurology Minute

Dr. Robert H. Gross discusses disease-modifying therapies in MS in the second part of a three-part series. To learn more, read the article "Monitoring, Switching, and Stopping Multiple Sclerosis Disease-Modifying Therapies" by Dr. Gross and Dr. John Corboy in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum . 

Dr. Philip Insel provides the main findings of his paper on determining clinically meaningful decline in preclinical Alzheimer disease. 

Dr. Sarah Tabrizi discusses the main findings of her study on targeting Huntington expression in patients with Huntington's Disease. Ready the May 6th article in NEJM:  https://www.nejm.org/doi/full/10.1056/NEJMoa1900907?query=recirc_curatedRelated_article

Dr. Robert H. Gross discusses disease-modifying therapies in MS in the first part of a three-part series. To learn more, read the article "Monitoring, Switching, and Stopping Multiple Sclerosis Disease-Modifying Therapies" by Dr. Gross and Dr. John Corboy in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum . 

Prof. Gil Wolfe discusses who might and might not be good candidates for thymectomy for non-thymomatous myasthenia gravis in the second part of his interview with Dr. Ted Burns. Read the full study in Lancet Neurology:  https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30392-2/fulltext . The study was also covered in Neurology Today, which you can read here:  https://journals.lww....

Dr. Orrin Devinsky summarizes his paper on the full spectrum of epilepsies and the North American SUDEP Registry. Listen to this week's full podcast for the entire interview.

Prof. Gil Wolfe summarizes his findings from his study on the long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis. Read the paper in Lancet Neurology:  https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30392-2/fulltext .  Additionally, see the Neurology Today article from March 7th featuring the study:  https://...

Dr. Jeffrey Ratliff discusses neurology residency programs, training, and action by the consortium of residency program directors.

Dr. Ted Burns discusses clinical recognition and diagnosis of MuSK myasthenia gravis.

Dr. Annette Langer-Gould discusses pregnancy and family planning with MS in the third of a three-part series. To learn more, read the article "Pregnancy and Family Planning in Multiple Sclerosis" by Dr. Langer-Gould in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum . 

Dr. Franziska Hopfner talks about the main takeaways from her paper on the u se of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.

Dr. Jerzy  Szaflarski talks about the FDA's approval of the first cannabis-derived pharmaceutical for the treatment of epilepsy and Lennox-Gastaut syndrome in particular. For more, read the full article, "The US Food and Drug Administration's Authorization of the First Cannabis-Derived Pharmaceutical: Are We Out of the Haze?" by Dr. Szaflarski in JAMA Neurology:  https://jamanetwork.com/journals/j...

Co-director Dr. Brian Hainline talks about new features and highlights of the 2019 AAN Sports Concussion Conference. The conference takes place July 26-28 in Indianapolis.

Dr. Annette Langer-Gould discusses pregnancy and family planning with MS in the second part of a three-part series. To learn more, read the article "Pregnancy and Family Planning in Multiple Sclerosis" by Dr. Langer-Gould in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum . 

Dr. Annette Langer-Gould discusses pregnancy and family planning with MS in the first of a three-part series. To learn more, read the article "Pregnancy and Family Planning in Multiple Sclerosis" by Dr. Langer-Gould in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum . 

Dr. Michelle Mauermann talks with Dr. Bart Jacobs about his paper on current treatment practice of Guillain-Barré syndrome.

Dr. Guy Rouleau discusses the main takeaways from his Neurology: Genetics paper on how the somatic expansion of the C9orf72 Hexanucleotide repeat does not occur in ALS spinal cord tissues.

Dr. Brian Dodick discusses highlights of the upcoming 2019 Sports Concussion Conference in Indianapolis.

Dr. Andrew J. Solomon discusses the diagnosis of multiple sclerosis in the second of a three-part series. To learn more, read the article "Diagnosis, Differential Diagnosis, and Misdiagnosis of Multiple Sclerosis" by Dr. Solomon in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum . This article is open to all at continpub.com/DiagnosisMS.

Dr. Andrew J. Solomon discusses the diagnosis of multiple sclerosis in the first of a three-part series. To learn more, read the article "Diagnosis, Differential Diagnosis, and Misdiagnosis of Multiple Sclerosis" by Dr. Solomon in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum . This article is open to all at continpub.com/DiagnosisMS.

Dr. Gross discusses a challenging experience from his time as Editor-in-Chief of Neurology, from the longer second part of the interview available through the Neurology Podcast.

Dr. Eoin Flanagan discusses NMOSD in the third of a three-part series. To learn more, read the article "Neuromyelitis Optica Spectrum Disorder and Other Non-Multiple Sclerosis Central Nervous System Inflammatory Diseases" by Dr. Flanagan in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum .

Dr. Jason Crowell discusses Richard Robinson's article on an antisense oligonucleotide therapy for a rare variant of Batten Disease. To learn more, read the article "An Antisense Oligonucleotide Therapy Looks Promising for a Rare Form of Batten Disease" by Robinson in the June 20, 2019, issue of Neurology Today —available online at http://bit.ly/NT-Batten .

Dr. Eoin Flanagan discusses NMOSD in the second of a three-part series. To learn more, read the article "Neuromyelitis Optica Spectrum Disorder and Other Non-Multiple Sclerosis Central Nervous System Inflammatory Diseases" by Dr. Flanagan in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum .

Dr. Eoin Flanagan discusses NMOSD in the first of a three-part series. To learn more, read the article "Neuromyelitis Optica Spectrum Disorder and Other Non-Multiple Sclerosis Central Nervous System Inflammatory Diseases" by Dr. Flanagan in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum .